(
A) Activity of AMPK in wild-type (lanes 1–2) and
SLC25A1Δ (lanes 3–4) HAP1 cells was assessed with antibodies against AMPK, phospho-AMPK, and SLC25A1. Cells were treated with AICAR at 0.4 mM concentration for 72 hr to induce the activation of AMPK (lanes 2 and 4). (
B) RNAseq determinations of FGF21 and GDF21 as well ATF transcription factors in wild-type and mutant cells. (
C) Cis-regulatory sequence analysis with iRegulon to infer transcriptional responses activated in the
SLC25A1Δ and
SLC25A4Δ upregulated transcriptome (1429 transcripts p<0.001 and log2 fold of change = 1) (
Janky et al., 2014). Significance threshold is set at 3. There are no ATF3, 4, or 5 target genes in the
SLC25A1Δ upregulated transcriptome. (
D) Activation of the mitochondrial stress response with doxycycline modestly increases APOE in conditioned media from
SLC25A1Δ cells but not in wild-type cells. MesoScale ELISA determinations of human APOE in wild-type and
SLC25A1Δ cells treated in the absence or presence of doxycycline at a concentration of 9.75 micromolar for 48 hr. APOE was measured in cell lysates and media. (
E–F) Activation of the mitochondrial stress response with doxycycline in wild-type (
D) and
SLC25A1Δ (
E) HAP1 cells. Doxycycline treatment was performed as in
C. Gene expression was determined by qRT-PCR measuring the transcription factors ATF3-5 and their selected target genes ASNS, CHAC1, CHOP, PCK2, and WARS. RER1 and PCBP1 were used as housekeeping control transcripts. n=3. (
G). Cells were treated with 2 mM N-acetyl cysteine (NAC) for 48 hr, n=3. RER1 was used as a control gene and glutathione-disulfide reductase (GSR) as a NAC-sensitive gene reporter. (
E to G) show data as a ratio between drug/vehicle. All figures depict average ± SEM. For
F and
G, One-way ANOVA followed by Šydák’s multiple correction. (
D and E) One-way ANOVA followed by Benjamini-Krieger-Yekuiteli multiple comparison corrections (FDR = 5%).